Equity Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Acquisitions, Joint Ventures and New Products Dominate Drug Manufacturer News
(firmenpresse) - JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 11/08/11 -- offers investors comprehensive research on the Drug Manufacturers - Other industry and has completed analytical research on (NASDAQ: TEVA) and (NYSE: FRX). Register with us today at to have free access to these researches.
The Drug Manufacturers - Other industry has been a hive of activity recently, with patent expiries, company takeovers and new products all factoring into the industry outlook. Companies such as Teva Pharmaceuticals Industries Ltd. have been busy of late with foreign expansions and domestic partnerships. Teva and Proctor & Gamble Co. have announced the particulars of their new joint venture which will be involved in bringing branded generic products to market. research report is accessible for free by registering today at .
is an online platform where investors doing their due-diligence on the Drug Manufacturers - Other industry can have easy and free access to our analyst research and opinions on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc.; investors and shareholders of these companies can simply register for a complimentary membership at .
While new markets and joint ventures can benefit companies, the industry relies heavily on research and development. Many new products have recently been announced by a plethora of companies in the industry, including Forest Laboratories Inc. The company, together with Ironwood Pharmaceuticals Inc., has recently stated that their new drug application, involving the treatment of irritable bowel syndrome, has been accepted for FDA review. research report is available for free by signing up now at .
As companies in the Drug Manufacturers - Other industry continue to make headlines it will be interesting to see which development strategy works best when year-end reports are released. Register now at to have free access to our reports on the Drug Manufacturers - Other industry.
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.11.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1054413
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
JOHANNESBURG, SOUTH AFRICA
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 39 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Equity Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Acquisitions, Joint Ventures and New Products Dominate Drug Manufacturer News
"
steht unter der journalistisch-redaktionellen Verantwortung von
StockCall (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
